Erytech Pharma
Latest round
- Series D
Last raised
- Apr 2013
Total raised
- $46M
Investors
- 5
About Erytech Pharma
Founded in 2004 in Lyon, France, Erytech Pharma SA specializes in developing innovative treatments for cancer and rare diseases. The company has undergone strategic business shifts to enhance its focus on these therapeutic areas. It was founded by Yann Godfrin, who has a history of entrepreneurial ventures in the biopharmaceutical field.400 mn.Erytech Pharma SA specializes in developing innovative therapies aimed at treating cancer and rare diseases. The company aims to explore new geographic markets in Europe and North America by the end of 2024, enhancing its reach and impact in the biopharmaceutical sector.
Who invested in Erytech Pharma
5 investors across 4 rounds
See all investors in Erytech Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Erytech Pharma
Who invested in Erytech Pharma?
Erytech Pharma has 5 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Erytech Pharma raised?
Erytech Pharma has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Erytech Pharma last raise money?
Erytech Pharma's most recent round on record is a Series D, in Apr 2013.
What does Erytech Pharma do?
Founded in 2004 in Lyon, France, Erytech Pharma SA specializes in developing innovative treatments for cancer and rare diseases.
Where is Erytech Pharma headquartered?
Erytech Pharma is headquartered in Lyon, France.
Which VCs invest in companies like Erytech Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Erytech Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Erytech Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.